Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose aspirin for fatigue in multiple sclerosis
ACTRN12610000353099Phase 4Recruiting
- Sponsor
- Nabriva Therapeutics plc
- Start
- May 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in multiple sclerosis (MS) comparing Aspirin 80 mg with Placebo (2 arms). Primary endpoints: Fatigue Impact Scale and Beck Depression Inventory II score. Started May 2010; status: recruiting.
02
Drugs
aspirin
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on ACTRN12610000353099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000353099.